Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis

被引:0
作者
Pengyong Luo
Xuli Yang
Shiren Huang
Shu Feng
Zongxing Ou
机构
[1] Haikou Hospital Affiliated to Xiangya Medical College,Department of Respiratory Medicine
[2] Central South University,undefined
来源
BMC Cancer | / 20卷
关键词
Syntenin; VEGF; Lung cancer; Expression; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 238 条
[1]  
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]  
Ferlay J(2000)Lung cancer Lancet 355 479-485
[3]  
Soerjomataram I(2005)Pathogenesis of lung cancer: 100 year report Am J Respir Cell Mol Biol 33 216-223
[4]  
Siegel RL(2016)Incorporation of Antiangiogenic therapy into the non-small-cell lung Cancer paradigm Clin Lung Cancer 17 493-506
[5]  
Torre LA(2017)Karnofsky award 2016: a lung Cancer journey, 1973 to 2016 J Clin Oncol 35 243-252
[6]  
Jemal A(2015)Interactions of multitargeted kinase inhibitors and nucleoside drugs: Achilles heel of combination therapy? Mol Cancer Ther 14 236-245
[7]  
Hoffman PC(2014)Antiangiogenic therapies: going beyond their limits Cancer Discov 4 31-41
[8]  
Mauer AM(2018)Syntenin-targeted peptide blocker inhibits progression of cancer cells Eur J Med Chem 154 354-366
[9]  
Vokes EE(2017)Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin Proc Natl Acad Sci U S A 114 370-375
[10]  
Miller YE(2015)Targeting tumor invasion: the roles of MDA-9/Syntenin Expert Opin Ther Targets 19 97-112